10 of our most read articles in 2023
PharmaVoice
DECEMBER 22, 2023
A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.
This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.
PharmaVoice
DECEMBER 22, 2023
A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.
STAT
JULY 18, 2023
This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top venture capital firms.” Read the rest…
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ALiEM - Pharm Pearls
NOVEMBER 3, 2023
2023.02.011 , PMID 36967275 Author information Chris Belcher, MD Editor, ALiEM AIR Series Assistant Professor and Assistant Program Director Department of Emergency Medicine University of Kentucky College of Medicine | Twitter | The post ALiEM AIR Series | Trauma 2023 Module appeared first on ALiEM. Ann Emerg Med. 2023;82(1):55-65.
Pharmacy Times
DECEMBER 30, 2023
From newsworthy moments to groundbreaking research, these were the most-read specialty pharmacy-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 29, 2023
From newsworthy moments to groundbreaking research, these were the most-read pediatrics-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 29, 2023
From newsworthy moments to groundbreaking research, these were the most-read oncology-related articles on Pharmacy Times in 2023.
STAT
DECEMBER 29, 2023
Below, you’ll find our top six most-read articles of the year by page views. And if your holiday plans mean you’re spending some time traveling, be sure to catch up with the “ First Opinion Podcast ,” where I speak with authors of recent First Opinion essays about their articles — and much more.
Pharmacy Times
DECEMBER 25, 2023
From newsworthy moments to groundbreaking research, these were the most-read Alzheimer disease-related articles on Pharmacy Times in 2023.
ALiEM - Pharm Pearls
OCTOBER 14, 2023
Author information Chris Belcher, MD Editor, ALiEM AIR Series Assistant Professor and Assistant Program Director Department of Emergency Medicine University of Kentucky College of Medicine | Twitter | The post ALiEM AIR Series | Respiratory 2023 Module appeared first on ALiEM. Please go to the above link.
Pharmacy Times
DECEMBER 23, 2023
From newsworthy moments to groundbreaking research, these were the most-read community pharmacy-related articles from Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 25, 2023
From newsworthy moments to groundbreaking research, these were the most-read pharmacy technician-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 24, 2023
From newsworthy moments to groundbreaking research, these were the most-read student-related articles on Pharmacy Times in 2023.
ALiEM - Pharm Pearls
JULY 20, 2023
Highlighted Quality Posts: Infectious Disease Site Article Author Date Label SGEM Lumbar punctures in febrile infants with positive urinalysis – it’s just overkill Dennis Ren, MD December 31, 2022 AIR EMDocs Bacterial Meningitis Mounir Contreras Cejin, MD January 28, 2023 HM ALiEM The Febrile Infant Corey Ziemba, MD, Justin Hacnik, MD and J.D.
Pharmacy Times
DECEMBER 26, 2023
From newsworthy moments to groundbreaking research, these were the most-read cardiovascular-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 27, 2023
From newsworthy moments to groundbreaking research, these were the most-read reimbursement-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 27, 2023
From newsworthy moments to groundbreaking research, these were the most-read pneumococcal-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 28, 2023
From newsworthy moments to groundbreaking research, these were the most-read coronavirus-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 25, 2023
From newsworthy moments to groundbreaking research, these were the most-read biosimilar-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 26, 2023
From newsworthy moments to groundbreaking research, these were the most-read Clostridioides difficile-related articles on Pharmacy Times in 2023.
Safe Biologics
JULY 20, 2023
ASBM Chair Presents Poster Abstract at DIA Global Annual Meeting 2023 On June 26th, ASBM Chairman Ralph McKibbin presented a poster at the DIA Global Annual Meeting in Boston, MA. Read the full article here (subscription required). Read ASBM Steering Committee Member Andrew Spiegel’s article about the small-molecule penalty here.
Safe Biologics
JULY 20, 2023
ASBM Chair Presents Poster Abstract at DIA Global Annual Meeting 2023 On June 26th, ASBM Chairman Ralph McKibbin presented a poster at the DIA Global Annual Meeting in Boston, MA. Read the full article here (subscription required). Read ASBM Steering Committee Member Andrew Spiegel’s article about the small-molecule penalty here.
Pharmacy Times
DECEMBER 29, 2023
From newsworthy moments to groundbreaking research, these were the most-read health systems-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 26, 2023
From newsworthy moments to groundbreaking research, these were the most-read heart failure-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 27, 2023
From newsworthy moments to groundbreaking research, these were the most-read skin cancer-related articles on Pharmacy Times in 2023.
Pharmacy Times
DECEMBER 23, 2023
From newsworthy moments to groundbreaking research, these were the most-read respiratory syncytial virus-related articles on Pharmacy Times in 2023.
Safe Biologics
NOVEMBER 12, 2023
ASBM to Present at World Drug Safety Congress Americas 2023 On October 19th, ASBM Advisory Board Chair Philip Schneider will present at the World Drug Safety Congress Americas 2023 in Boston, Massachusetts. Register for the 2023 National Policy & Advocacy Summit on Biologics here. Read the new FDA’ Guidance here.
Safe Biologics
JANUARY 12, 2024
The paper’s content is drawn from a webinar on the same topic hosted by ASBM and GaBI on July 26, 2023. Read the full JD Supra article here. Stelara was recently selected by the Center for Medicare & Medicaid Services (“CMS”) as one of the first 10 drugs subject to the Inflation Reduction Act’s (“IRA’s”) price negotiations.
European Pharmaceutical Review
JANUARY 29, 2024
N-Nitrosamines By far the biggest issue bedevilling industry during 2023 was the continuing N-nitrosamine contamination saga, which was covered in the third issue of EPR 2023. During August 2023 the FDA also updated its guidance for NDSRIs 7 and it was closely aligned (but not identical) to EMA’s evolving guidance.
Safe Biologics
DECEMBER 6, 2023
ASBM to Exhibit at ACR Convergence 2023 Visit ASBM at Booth #2612 at ACR Convergence in San Diego, CA, November 12-14th. ASBM to Present at World Drug Safety Congress Americas 2023 On October 19th, ASBM Advisory Board Chair Philip Schneider presented at the World Drug Safety Congress Americas 2023 in Boston, Massachusetts.
Pharmaceutical Commerce
DECEMBER 29, 2023
Popular works in the category explore 340B guidelines, ‘smart pharma’ capabilities, and commercialization trends.
Drug Channels
DECEMBER 13, 2023
Click here to see the original post from September 2023. For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.
STAT
FEBRUARY 23, 2024
In 2023, STAT launched a brand-new home for our subscribers to connect with each other and with their favorite STAT journalists.
Pharmaceutical Commerce
DECEMBER 26, 2023
Items in this sector ranged touched on topics such as pharma shipping, container technology, and sustainability.
STAT
AUGUST 8, 2023
This article is adapted from STAT’s latest report, “2023 Update: ranking biotech’s top venture capital firms.” ” Right now, venture capital firms are struggling with the impact of a persistently anemic biotech market. Read the rest…
European Pharmaceutical Review
SEPTEMBER 7, 2023
A key part of Annex 1, due to come into effect on 25 August 2023, is the development of a holistic contamination control strategy (CCS). In this article, EPR’s Caroline Peachey summarises an expert panel discussion, which explored common challenges in implementing a CCS and made several recommendations.
Drug Channels
SEPTEMBER 13, 2023
For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. Time for our annual update on the channels for provider-administered drugs. d/b/a Drug Channels Institute.
European Pharmaceutical Review
FEBRUARY 22, 2023
Computed tomography for in-depth investigation of freeze-dried products In this article, Teresa Siegert and Henning Gieseler, discuss the benefits of applying computed tomography in the production of freeze-dried pharmaceutical products, as well as the hurdles that must be navigated to realise its potential.
European Pharmaceutical Review
NOVEMBER 9, 2023
Issue 5 of European Pharmaceutical Review features articles on manufacturing, development and quality control of biopharmaceuticals from antibodies to mRNA and cell and gene therapies. We also explore opportunities for outsourcing of regulatory activities, the challenges of paediatric drug formulation and much more.
Med Ed 101
DECEMBER 18, 2022
The 2023 BCPS exam will not undergo significant changes compared to 2022. There are no planned changes to the content outline for 2023. In this article, I will outline previous pass rates, […]. The post 2023 BCPS Exam – What You Need To Know appeared first on Med Ed 101.
European Pharmaceutical Review
FEBRUARY 2, 2023
The winners of Pharmapack Europe’s 2023 awards have been announced, presented across a range of innovative recyclable packaging, drug delivery solutions, and reusable connected devices. Three categories were available for entry in the Exhibitor Innovations section.
Digital Pharmacist
AUGUST 21, 2023
As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. 2023 Flu Vaccination Changes As we look at the 2023-2024 flu season, what’s new for this year?
Drug Channels
NOVEMBER 1, 2022
Open enrollment is under way for the 2023 Medicare Part D plans. For 2023: 98% of stand-alone Medicare Part D prescription drug plans (PDP) will have a preferred network. Below, I provide historical data on preferred networks’ growth and update the top companies’ 2023 offerings. d/b/a Drug Channels Institute.
The Honest Apothecary
MAY 3, 2023
Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. All article shared will be free to read and not locked behind an annoying paywall. The post Pharma á la carte – 05/04/2023 appeared first on The Honest Apothecary. ” MENTAL FLOSS.
STAT
MARCH 17, 2023
Bibbins-Domingo, who previously worked at the University of California, San Francisco, was named this week as a member of the 2023 STATUS List of people making a difference in health care and life sciences. She recently spoke at the annual conference of the Association of Health Care Journalists, in St.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content